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Abstract
Background: We have previously found regional differences in the prevalence of known type 2 diabetes between
northeastern and southern Germany. We aim to also provide prevalence estimates for prediabetes (isolated impaired fasting
glucose (i-IFG), isolated glucose intolerance (i-IGT), combined IFG and IGT) and unknown type 2 diabetes for both regions.
Methods: Prevalence (95%CI) of prediabetes (i-IFG: fasting glucose 5.6–6.9 mmol/l; i-IGT: 2 h postchallenge gluose 7.8–
11.0 mmol/l, oral glucose tolerance test (OGTT), $8 h overnight fasting) and unknown diabetes were analyzed in two
regional population-based surveys (age group 35–79 years): SHIP-TREND (Study of Health in Pomerania (northeast), 2008–
2012) and KORA F4 (Cooperative Health Research in the region of Augsburg (south), 2006–2008). Both studies used similar
methods, questionnaires, and identical protocols for OGTT. Overall, 1,980 participants from SHIP-TREND and 2,617
participants from KORA F4 were included.
Results: Age-sex-standardized prevalence estimates (95%CI) of prediabetes and unknown diabetes were considerably
higher in the northeast (SHIP-TREND: 43.1%; 40.9–45.3% and 7.1%; 5.9–8.2%) than in the south of Germany (KORA F4: 30.1%;
28.4–31.7% and 3.9%; 3.2–4.6%), respectively. In particular, i-IFG (26.4%; 24.5–28.3% vs. 17.2%; 15.7–18.6%) and IFG+IGT
(11.2%; 9.8–12.6% vs. 6.6%; 5.7–7.5%) were more frequent in SHIP-TREND than in KORA. In comparison to normal glucose
tolerance, the odds of having unknown diabetes (OR, 95%CI: 2.59; 1.84–3.65) or prediabetes (1.98; 1.70–2.31) was higher in
the northeast than in the south after adjustment for known risk factors (obesity, lifestyle).
Conclusions: The regional differences of prediabetes and unknown diabetes are in line with the geographical pattern of
known diabetes in Germany. The higher prevalences in the northeast were not explained by traditional risk factors.
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Introduction
According to the sixth edition of the IDF Diabetes atlas [1],
considerable regional differences in the prevalence of type 2
diabetes (age-adjusted) exist between European nations ranging
from 2.4% in Moldova to more than 14% in Turkey [2]. While
geographic variations in diabetes prevalence between nations are
well known, regional differences within countries are rarely
analyzed. Especially, information on regional variation of predi-
abetes and unknown (undiagnosed) diabetes is lacking. In the
USA, the Behavioral Risk Factor Surveillance System identified
higher prevalence estimates of known (diagnosed) type 2 diabetes
of 11.7% in the adult population of the southeastern area
(‘‘diabetes belt’’) while the comparative estimate was 8.5% for
the rest of the country [3]. In a meta-analysis of regional surveys in
the Diabetes Collaborative Research of Epidemiologic Studies
(DIAB-CORE consortium) we found a high prevalence of known
type 2 diabetes in the northeastern regions of Germany with
10.9% in Pomerania (Vorpommern) and a comparatively low
prevalence of 5.8% in the south [4]. However, it remained unclear
whether a higher awareness and screening for the disease among
general practitioners and in the population led to a lower
frequency of undiagnosed diabetes, or whether a higher morbidity
itself may have contributed to higher prevalence estimates in the
northeast. Therefore, we compared age- and sex-specific estimates
for prediabetes and unknown diabetes in two German regions –
one in the northeast (Pomerania, SHIP-TREND) and one in the
south (Augsburg region, KORA F4) using oral glucose tolerance
tests (OGTT, ADA criteria) [5]. The study sampling and standard
operating procedures of SHIP-TREND were largely similar to
KORA F4 (including OGTT) in order to provide a high
comparability between the two studies.
Methods
Study population SHIP-TREND (northeastern Germany)
A sample of 8,826 adults aged 20–79 years with German
nationality was drawn from the central population registry of
Western Pomerania (212,157 inhabitants living in Greifswald,
Stralsund, Anklam and surrounding counties). A two-stage cluster
sampling method was adopted from the WHO Multinational
Monitoring of Trends and Determinants in Cardiovascular
Disease (MONICA) Project in Augsburg, Germany. Stratification
variables were age, sex, and city/county of residence [6]. Of all
persons invited, 4,420 (50.1%) individuals participated in the
examinations (2008–2012). All participants provided written
informed consent and the medical ethics committee of the
University of Greifswald approved the study protocol. Further
information on the study design of the SHIP-TREND survey has
been published elsewhere [6,7].
Study population KORA F4 (southern Germany)
The KORA F4 study is the follow-up of the KORA S4 survey
which was carried out in 1999–2001 in the city of Augsburg and
16 municipalities from the surrounding counties (about 600,000
inhabitants). The re-investigation took place in 2006–2008
(KORA F4). A two-stage cluster sampling method was used
which followed the WHO MONICA project method in the
Augsburg region. For Augsburg city, a simple random sampling
was performed. In the surrounding rural districts, 16 counties were
selected with probabilities proportional to their size [8]. Of 6,640
participants with German nationality aged 25–74 years, 4,261
participated at the baseline examinations S4. In KORA F4, 3,080
(72%) S4 participants were re-investigated. At baseline, an oral
glucose tolerance test (OGTT) was administered to all 1,353 non-
diabetic subjects in the age group 55–74 years [9]. Younger
participants were not screened for undiagnosed diabetes. At
follow-up, OGTT measurements were carried out without age
restriction after exclusion of individuals with known diabetes
[9,10]. For the current study, the cross-sectional data of KORA F4
was analyzed only. The OGTT-based screening for unknown
diabetes in KORA S4 in age group 55–74 years at baseline, (62–
82 years at follow-up) might have resulted in an early diagnosis of
diabetes and therefore in a lower number of unknown diabetes at
follow-up. Because of this methodological difference to SHIP-
TREND, we report results for younger (,60 years) and older
participants separately. All study participants gave written
informed consent to the study, which was approved by the Ethics
Committee of the Bavarian Medical Association.
Laboratory analyses including glucose measurements
In both studies, blood was collected without stasis after an
overnight fast of $8 hours. After blood withdrawal the blood
samples were immediately centrifuged and kept cool (4uC) until
analysis of blood glucose in the central laboratory. Measurements
of fasting glucose and 2 h glucose were based on plasma in SHIP-
TREND and on serum in KORA F4. In order to determine
whether both samples were comparable, duplicate measurements
were carried out using serum samples of all SHIP-TREND
participants. Both measurements (plasma and serum glucose) were
highly correlated (r = 0.99; p,0.0001). In Passing Bablok regres-
sion analysis of serum versus plasma glucose (mmol/l) an intercept
of 20.10 (95%CI 20.10; 20.10) and a slope of 1 were observed
concluding that plasma values in SHIP-TREND might be only
slightly lower than serum values. Furthermore, 30 serum blood
glucose samples were drawn at random from KORA F4 and re-
assessed in the SHIP-TREND laboratory, yielding a correlation
coefficient of r = 0.94 (p,0.0001). On average, these original 30
KORA F4 measurements were only slightly lower (mean 2
0.06 mmol/l; SD 0.17) when they were re-analyzed in the SHIP-
TREND laboratory. Thus, serum glucose from KORA F4 and
plasma glucose from SHIP-TREND were considered as compa-
rable for the current analysis.
HDL-, LDL- and total cholesterol, and triglycerides were
measured as described elsewhere [6,11].
Ascertainment of diabetes and prediabetes in
SHIP-TREND and KORA F4
Oral glucose tolerance tests followed concordant standardized
operating procedures (SOP) in both studies [9]. Participants were
asked to fast for $8 hours except for water (eg. from 22:00 p.m.)
and should not smoke or consume caffeine containing drinks, such
as coffee and avoid sports before the examination. In SHIP-
TREND and KORA F4, OGTTs were completed during
morning hours. Fasting glucose was sampled, and 75 grams of
anhydrous glucose (Dextro OGT; Boehringer Mannheim, Mann-
heim Germany) was given to participants without known diabetes
(SHIP-TREND: known diabetes or current use of glucose-
lowering agents; KORA F4: current use of glucose-lowering
agents or unknown (newly study-diagnosed) diabetes at baseline
(S4), validated by a physician). Fasting glucose and 2 h postload
glucose were measured using a hexokinase method. In SHIP-
TREND, Dimension Vista by Siemens Healthcare Diagnostics
(Eschborn, Germany) and in KORA F4, GLU flex by Dade
Behring (Marburg, Germany) were used.
Participants with fasting glucose values ,5.6 mmol/l (,
100 mg/dl) and 2 h glucose ,7.8 mmol/l (,140 mg/dl) were
defined as having normal glucose tolerance (NGT) (5). Fasting
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glucose values $7.0 mmol/l ($126 mg/dl) or 2 h glucose $
11.1 mmol/l ($200 mg/dl) were classified as unknown diabetes.
Prediabetes was diagnosed if fasting glucose values ranged between
5.6 and 6.9 mmol/l (100–125 mg/dl, i-IFG) and/or 2 h postload
glucose values between 7.8 and 11.0 mmol/l (140–199 mg/dl, i-
IGT). Participants were categorized to three groups of prediabetes
(glucose disturbances): isolated impaired fasting glucose (i-IFG),
isolated impaired glucose tolerance (i-IGT), and combined IFG
and IGT (IFG+IGT).
Anthropometry, interviews and medical information in
SHIP-TREND and KORA F4
In both studies, trained and certified personnel collected
information on sociodemographic variables, lifestyle habits and
medical history by the following common standardized personal
interviews. Participants were asked to bring original packaging of
their medications that were taken during the last 7 days before the
examination date. Unique identifiers and drug names were
recorded according to the Anatomical Therapeutical Chemical
(ATC) classification system.
Trained staff measured height and weight of participants
wearing lightweight clothing without shoes. Blood pressure was
measured in sitting position using a validated automatic device
(SHIP-TREND and KORA F4: OMRON HEM 705-CP). Three
independent measurements were taken in three-minute-intervals
after an initial rest of at least 5 minutes. The mean of the second
and third blood pressure measurement was calculated in both
studies and used for the analysis.
Lifestyle and socioeconomic indicators
Physical activity level was based on self-reported time per week
spent on sports during leisure time in summer and winter. Low
exercise level activities such as stepping stairs or walking were not
assessed. Participants were considered as inactive if their leisure
time exercise comprised ,1 h per week in summer or winter.
Participants were classified as smokers if they smoked at least
one cigarette per day and as non-smokers if they were either never
smoking or stopped smoking at least 12 month ago. Alcohol
consumption (in g/day) was calculated from self-reported
consumption of beer, wine, and liquors per week.
Educational level was assessed by highest self-reported schooling
degree achieved. Low education was defined as #9 years of
schooling either with school leaving certificate (completed lower
secondary education level) or without.
Study population
The study is based on participants aged 35 to 79 years (SHIP-
TREND: n = 3,624; KORA F4: n = 2,929). Participants were
excluded from the analyses of pre-diabetes states if one of the
following criteria was met: self-reported, known diabetes, or
diabetes treatment (SHIP-TREND: n = 430; KORA F4: n = 225),
missing information on known diabetes (SHIP-TREND: n = 12;
KORA F4: n = 86), or missing or implausible values in glucose
measurements (SHIP-TREND: n = 536; KORA = 1).
All participants who underwent glucose challenge testing were
required to be in the fasting state ($8 hours overnight fasting). In
SHIP-TREND, however, 666 participants without known diabe-
tes were not fasting for 8 hours. Therefore, estimates for known
diabetes are reported for the complete sample including non-
fasting participants (SHIP-TREND: n = 3,624; KORA F4:
n = 2,928). For the estimation of unknown diabetes or prediabetes,
participants who did not meet fasting criteria were excluded from
analysis. These ‘‘non-fasting’’ 666 participants from SHIP-TREND
had a lower proportion of women (43.5% vs. 54.6%; p,0.0001),
lower HDL-cholesterol (1.4 mmol/l vs. 1.5 mmol/l; p = 0.001) and
higher triglycerides (median 1.6 vs. 1.3 mmol/l; p,0.0001) than the
1,980 participants with 8 h overnight fasting. However, both groups
from SHIP-TREND – fasting versus non-fasting participants – did
not differ in age, body mass index, total cholesterol, LDL-
cholesterol, blood pressure, fasting and 2 h glucose. Therefore,
the additional analyses on regional differences in known diabetes
include all 3,491 participants from SHIP-TREND and 2,928
participants from KORA F4, whereas the main analyses on
prediabetes and unknown diabetes are based on 1,980 participants
from SHIP-TREND and 2,617 participants from KORA F4.
Statistical analysis
For descriptive analyses, mean (SD) were calculated for
continuous variables and proportions for categorical variables.
Differences between study regions were calculated using Wil-
coxon-Test for metric and Fisher’s exact test for dichotomous
variables. Statistical significance was set at p,0.05. Prevalence
estimates for prediabetes and unknown diabetes were directly
standardized to the German adult population (31st December
2007). Logistic regression models were carried out to determine
factors associated with either unknown diabetes or prediabetes.
Models were fitted adjusting for age, sex, BMI, physical activity,
smoking, alcohol consumption, and formal schooling. Analyses
were performed using SAS statistical software version 9.3 (SAS
Institute Inc., Cary, NC, USA). Distribution of fasting glucose and
2 h glucose were plotted with RStudio (RStudio, Inc., Boston,
USA) using the kernel density estimation as a method to estimate
the probability density function.
Results
In the complete sample of both studies including individuals
with known diabetes and non-fasting individuals aged 35–79 years,
age-sex-standardized prevalence of known diabetes was 11.9%
(95%CI: 10.8–13.0%) in the northeast and 6.5% (5.2–7.8%) in the
south. Individuals with type 2 diabetes from the northeast were
younger (63 vs. 67 years; p,0.0001), had higher fasting glucose
levels (8.7 vs. 7.7 mmol/l, p = 0.01), a higher body mass index
(32.4 vs. 31.3 kg/m2; p = 0.02), higher blood pressure (systolic:
137.8 vs. 132.3 mmHg, p,0.001; diastolic: 78.3 vs. 74.4 mmHg;
p,0.001), and higher triglycerides (median: 2.0 vs. 1.6 mmol/l;
p = ,0.001), but slightly lower cholesterol levels (total: 5.1 vs.
5.3 mmol/l; p = 0.07; HDL-Cholesterol: 1.26 vs. 1.27 mmol/l,
p = 0.28; LDL-C: 3.1 vs. 3.3 mmol/l, p = 0.011) (Table S1).
For the analysis of prediabetes and unknown diabetes,
participants with known diabetes and with a fasting period of ,
8 hours were excluded, leaving 1,980 participants from SHIP-
TREND (1,080 women; 900 men) and 2,617 participants (1,379
women; 1,239 men) from KORA F4. The characteristics of these
participants are shown in Table 1. SHIP-TREND participants
were slightly younger, but had a higher body mass index, higher
blood pressure values, increased triglycerides and elevated fasting
and 2 h glucose. The participants of both regions did not differ in
cholesterol levels (HDL-cholesterol, LDL-cholesterol and total
cholesterol).
The age- and sex-specific distributions of fasting and 2 h glucose
values are shown for both study regions in Figures 1 and 2. The
distributions were shifted towards generally higher levels both for
fasting and 2 h glucose in SHIP-TREND compared to KORA F4.
This shift was more pronounced in those with NGT, in particular
in the age-group 35–59 years. In this group, the mean difference
between the two regional populations for 2 h glucose was
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0.3 mmol/l (95%CI: 0.2–0.4 mmol/l). In older individuals with
NGT, this mean difference was similar, with slightly wider
confidence intervals (0.3; 0.1–0.4 mmol/l). In participants with
prediabetes and undiagnosed diabetes this pattern was less clear
and differences did not reach statistical significance.
After age- and sex-standardization to the German population
(31.12.2007), the prevalence (95%CI) of unknown diabetes was
almost twofold higher in the northeast than in the south (7.1%;
5.9–8.2% vs. 3.9%; 3.2–4.6%). Overall, prediabetes (IFG, IGT or
both) was also more prevalent in the northeast (43.0%; 40.8–
45.1%) than in the south (30.1%; 28.4–31.7%) (Figure 3).
After stratification for age and sex, the crude estimates of
prediabetes were significantly higher in the northeast than in the
south in the younger age-groups 35–44 years, 45–54 years, and
55–64 years (Table 2). Prediabetes prevalence was also 2.2-fold
higher in males and 2.7-fold higher in women aged 35–44 years.
This sex-difference leveled off with increasing age-group and was
reversed in men aged 75–79 years, however, not reaching
statistical significance.
With respect to the three subgroups of prediabetes, regional
differences in age- and sex-standardized prevalence were signifi-
cant both for i-IFG and combined IFG+IGT, but did not reach
level of statistical significance for i-IGT (SHIP-TREND: i-IFG
Table 1. Characteristics of the two population-based regional surveys: SHIP-TREND (northeast) and KORA F4 (south)*.
SHIP-TREND KORA F4 p-value
N 1,980 2,617
Female sex (%) 54.6 52.7 0.221
Age (years) 54.0 (11.4) 55.5 (12.2) ,0.001
Fasting glucose (mmol/l) 5.6 (0.8) 5.3 (0.6) ,0.001
2 h glucose (mmol/l) 6.7 (2.4) 6.2 (2.1) ,0.001
Body mass index (kg/m2) 28.1 (4.8) 27.4 (4.6) ,0.001
Systolic blood pressure (mmHg) 126.6 (17.3) 121.6 (18.3) ,0.001
Diastolic blood pressure (mmHg) 77.6 (9.8) 75.4 (9.8) ,0.001
Total cholesterol (mmol/l) 5.6 (1.1) 5.6 (1.0) 0.901
HDL-cholesterol (mmol/l) 1.5 (0.4) 1.5 (0.4) 0.571
LDL-cholesterol (mmol/l) 3.5 (0.9) 3.5 (0.9) 0.105
Triglycerides (mmol/l), median (IQR) 1.3 (0.9–1.8) 1.3 (0.9–1.8) ,0.001
*Results are means (SD), proportions (%) or median (IQR). P-values are calculated using Wilcoxon-Test for metric and Fisher’s exact test for dichotomous variables.
Abbreviations: SHIP-TREND: Study of Health in Pomerania (2008–2012); KORA F4: Cooperative Health Research in the Region of Augsburg;
The sample was restricted to participants without known diabetes and to participants who were fasting for $8 hours.
doi:10.1371/journal.pone.0113154.t001
Figure 1. Kernel densities for fasting glucose in mmol/l per study region stratified for age group and sex. Solid line: KORA F4; dashed
line: SHIP-TREND.
doi:10.1371/journal.pone.0113154.g001
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26.4% (24.5–28.3%); combined IFG+IGT 11.2% (9.8–12.6%);
KORA F4: i-IFG; combined IFG+IGT 17.2% (15.7–18.6%) and
6.6% (5.7–7.5%)).
Table 3 shows age- and sex-specific prevalence estimates for i-
IFG, i-IGT, and combined IFG+IGT and unknown diabetes. I-
IFG was the most common glucose disturbance in both regions.
Prevalence of i-IFG was more than two-fold increased in the
northeast in men aged 35–44 years and in women aged 45–54
years compared to the south (Table 3). Among individuals with i-
IGT no significant regional differences were found in any age
group. In combined IFG and IGT, prevalence was increased in
the northeast in comparison to the south in both sexes only in the
Figure 2. Kernel densities for 2 h glucose in mmol/l per study region stratified for age group and sex. Solid line: KORA F4; dashed line:
SHIP-TREND.
doi:10.1371/journal.pone.0113154.g002
Figure 3. Prevalence of prediabetes (Pre-DM = i-IFG, i-IGT or combined IFG+IGT) and unknown diabetes (New-DM) in two German
regions, standardized to the German population (31/12/2007).
doi:10.1371/journal.pone.0113154.g003
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complete sample aged 35–79 years. Furthermore, prevalence of
undiagnosed diabetes was significantly increased in men aged 35–
79 years from northeast, while the difference was not significant in
women.
Finally, the odds of having unknown diabetes or prediabetes
were about twofold increased in the northeast in comparison to the
south (univariate OR: unknown diabetes vs. NGT: 2.12, 1.67–
2.82; univariate OR: prediabetes vs. NGT: 1.78, 1.57–2.01). The
association of glucose disorders with region was not explained by
traditional risk factors and became even stronger after controlling
for age, sex, BMI, physical activity, smoking, alcohol consumption
and education. (ORadj.: unknown diabetes vs. NGT: 2.59, 1.84–
3.65; ORadj.: prediabetes vs. NGT: 1.98, 1.70–2.31).
Discussion
Our study shows that age-sex-standardized prevalence of
unknown diabetes is considerably higher in the northeast than in
the south of Germany (age group 35–79 years). Regional
differences in prediabetes followed a similar northeast-south
gradient and were more pronounced in the younger (35–59 years)
than in the older age group (60–79 years). Thus, the prevalence of
prediabetes in individuals from the northeast was largely
comparable with that from individuals from the south, who were
about 10 (women) to 20 years (men) older. Overall, regional
differences were not explained by traditional risk factors such as
BMI, physical activity, smoking, or low education.
This regional variation is in line with previous data on known
type 2 diabetes prevalence in five regional population-based
studies (DIAB-CORE), in nationwide health insurance data, and
in a nationwide telephone survey (GEDA 2010) [4,12,13]. The
increased prevalence of prediabetes and undiagnosed diabetes in
the northeast in comparison to the south suggests that different
diabetes screening activities are not likely to explain the regional
differences in diabetes prevalence in Germany. Furthermore, a
recent study based on the follow-up examinations in the DIAB-
CORE consortium found that type 2 diabetes incidence (per 1,000
person-years) was also higher in the northeast than in the south of
Germany (northeast: 13.2 (95%CI 10.9–16.1); south: 9.3 (7.7–
11.3)) [14]. The present finding of a higher (pre)diabetes risk is in
line with earlier reports on increased waist circumference levels,
higher blood pressure and an increased (cardiovascular) mortality
in Northeastern than in Southern Germany [15–17].
Previous results from our DIAB-CORE consortium suggested
that regional deprivation, in particular the unemployment rate on
municipality and neighborhood level partially explained the
regional differences in known type 2 diabetes [18,19]. These
relationships were independent of obesity or individual socioeco-
nomic status [18,19]. Regional deprivation may also contribute to
the regional differences in unknown diabetes and prediabetes. In
this context, it is conceivable that relocation of healthier
inhabitants to wealthier regions, which offer more jobs and a
better overall infrastructure, may leave behind inhabitants with a
generally higher morbidity and less healthy lifestyle.
It might also be of importance that the two study areas have
been part of two different states during the years 1949–1990. The
northeastern region of SHIP-TREND was part of the German
Democratic Republic (GDR) and the southern region of KORA
F4 was part of the Federal Republic of Germany (FRG). Both
states differed considerably in their legislation, governmental,
health care, and economic systems. Almost 25 years after
reunification, persisting diversities have been reported which
might be relevant for the different (pre)diabetes risk. First, in 1998,
nutrition still differed between both regions [20]. As an example,
tea, coffee and drinking water consumption was significantly lower
in the former GDR than in the former FRG states, while the
situation was inverse for soft drinks [20]. Furthermore, fruits were
consumed more frequently in the territories of the former GDR,
while leafy greens and other vegetables were predominantly
consumed in the FRG [20]. Similar nutritional differences were
found in a comparison of the EPIC-Potsdam (northeast) with the
EPIC-Heidelberg (southwest) study [21]. Second, fetal and infant
growth plays a role in the development of type 2 diabetes [22].
During the first years after reunification, combined statistics
Table 2. Prevalence of prediabetes (i-IFG, i-IGT or combined IFG+IGT) in the northeast (SHIP-TREND) and south (KORA F4) of
Germany*.
Age (years) SHIP-TREND KORA F4
N 1,980 2,617
Men
35–44 43.5 (36.8–50.4) 20.2 (15.8–25.2)
45–54 50.4 (44.0–56.8) 35.2 (29.7–41.1)
55–64 57.8 (51.2–64.3) 44.3 (38.7–50.1)
65–74 58.2 (50.1–66.0) 52.3 (46.0–58.6)
75–79 43.8 (29.5–58.8) 52.7 (42.1–63.1)
Women
35–44 19.9 (15.4–25.1) 7.3 (4.7–10.6)
45–54 30.9 (25.8–36.4) 14.7 (11.2–18.9)
55–64 45.5 (39.6–51.4) 30.7 (25.7–36.1)
65–74 49.2 (41.7–56.7) 44.1 (38.2–50.0)
75–79 48.5 (30.8–66.5) 41.9 (31.3–52.9)
*The sample was restricted to participants without known diabetes and to participants who were fasting for $8 hours. Results are crude prevalence estimates (%) and
95% confidence intervals. Significant regional differences (p,0.05) are highlighted in bold.
Abbreviations: SHIP-TREND: Study of Health in Pomerania (2008–2012); KORA F4: Cooperative Health Research in the Region of Augsburg (2006–2008). I-IFG (isolated
impaired fasting glucose: 5.6–6.9 mmol/l (100–125 mg/dl), fasting); i-IGT (impaired glucose tolerance: 7.8–11.0 mmol/l (140–199 mg/dl), 2 hour postload).
doi:10.1371/journal.pone.0113154.t002
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showed that perinatal mortality was increased in the territories of
the former GDR in comparison to the federal states of the FRG
[23]. It is conceivable that the perinatal mortality was also
increased in the Northeast during the time when the study
population of SHIP-TREND was born [23]. However, since 2000,
perinatal mortality has declined in both regions and is currently
lower in the territories of the former GDR. It is noteworthy, that a
recent analysis of the German Perinatal Survey (2007–2011)
reported a lower body length at birth for the neonates in the
territories of the former GDR while there was no clear geographic
pattern for preterm birth rate, birth weight, or the percentage of
neonates with birth weight $4,500 g [24]. However, whether
infant growth patterns, pancreas and liver development, may
contribute to the regional differences in diabetes and prediabetes
remains unclear.
There are few studies available on regional differences in
diabetes prevalence from other countries. In China, regional
differences in known and unknown type 2 diabetes seemed to arise
from differences in urban and rural lifestyles [25]. While type 2
diabetes (known and unknown combined) was more frequent in
urban areas (6.9% vs. 5.6%), the proportion of undiagnosed type 2
diabetes in total diabetes was higher in rural areas (70.5% vs.
58.0%). Urban-rural differences might not be relevant in our study
because both regions have a similar geographic distribution of
towns and rural areas. Therefore, novel risk factors for diabetes
such as traffic-related air pollution (e.g. particle pollution, nitrogen
oxides), job strain, emotional stress, anxiety or depressive disorders
and the potential mediating role of inflammation need to be
considered in future studies [26–29].
Regional differences in undiagnosed (pre)diabetes have impor-
tant implications for health care planning. A meta-analysis
demonstrated that individuals with prediabetes were 5–10 times
more likely to develop diabetes annually than normoglycaemic
individuals [30]. It has been estimated that up to 70% of
individuals with prediabetes will develop diabetes over the course
of life [31]. Furthermore, undiagnosed diabetes is associated with
an increased mortality [32,33]. In individuals with prediabetes an
increased risk for neuropathy, nephropathy, retinopathy, and
macrovascular disease has been described [31,34]. In line with
these observations, drug treatment costs were already increased in
persons with prediabetes and unknown type 2 diabetes, when
compared to individuals with normal glucose tolerance [35].
From a public health perspective, diabetes prevention strategies
should take into account these regional characteristics [36,37].
Our results indicate that type 2 diabetes prevention in Germany
potentially needs to start at fairly young age (at least before the age
of 35) in the northeast, whereas prevention in the south –
especially in females - may possibly focus more on middle-aged
populations.
Some limitations of the study have to be mentioned. First, in
SHIP-TREND plasma glucose has been examined, while in
KORA F4 serum glucose was analyzed. However, fasting plasma
glucose and fasting serum glucose were compared in SHIP-
TREND showing a high agreement between both methods.
Second, KORA F4 is a follow-up survey and examinations have
been carried out seven years after baseline examinations. At
baseline, OGTTs were administered to all participants aged 55
years and older. Thus, exclusion of individuals with type 2 diabetes
in this age group encompassed unknown diabetes and known
diabetes, while only persons with known diabetes were excluded in
SHIP-TREND. This might have influenced the results in older
age groups. Therefore, we report results for younger and older
participants separately. Furthermore, the SHIP-TREND study
started examinations in 2008 (lasting until 2012) when the
examinations in KORA F4 were already finished. The difference
of four years on average in data collection might have influenced
the results, however, probably only to a small degree.
The strength of the study is the large number of well-
characterized participants that underwent OGTTs following
common standardized protocols.
In conclusion, men and women in the northeast of Germany
have a considerably higher prevalence of prediabetes (IFG, IGT or
both) and unknown type 2 diabetes than their counterparts in the
south of Germany. In particular, prediabetes is more prevalent at
younger age in the northeast. Therefore, prevention strategies and
health care policy need to take into account these regional
differences in morbidity and diabetes risk. Further studies are
warranted to examine the risk factors underlying these regional
differences, in particular, the impact of individual and regional
socioeconomic indicators.
Supporting Information
Table S1 Characteristics of excluded participants with
type 2 diabetes in SHIP-TREND and KORA F4*. *Results
are means (SD), proportions (%) or Median (IQR). P-values were
calculated using Wilcoxon-Test for metric and fisher exact test for
dichotomous variables. Missing values in KORA: 14 for fasting
glucose, 5 in BMI, 1 for BP and lipids. Missing values in SHIP-
TREND: 1 for FPG and BMI, 3 for BP and lipids. Abbreviations:
SHIP-TREND: Study of Health in Pomerania (2008–2012);
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15. Stang A, Döring A, Völzke H, Moebus S, Greiser KH, et al. (2011) Regional
differences in body fat distributions among people with comparable body mass
index: a comparison across six German population-based surveys. Eur J Car-
diovasc Prev Rehabil 18: 106–114.
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